Ketorolac in Hand and Wrist Tendinopathy and Arthropathy
Status:
Not yet recruiting
Trial end date:
2024-12-01
Target enrollment:
Participant gender:
Summary
Osteoarthritis (OA) and inflammatory conditions of the tendons and joints of the hand and
wrist are common yet disabling diseases. Standard management utilizes conservative measures
to minimize pain and improve function. Conservative pharmacological management commonly
includes corticosteroid and ketorolac injections which have been well investigated as a
modality of pain control and improved function in large joint OA. However, fewer studies
yielding mixed results on the duration of symptomatic relief exist for arthropathy and
tendinopathy of the hand and wrist.
The goal of this study is to evaluate the efficacy of ketorolac and triamcinolone injections
for common hand and wrist tendinopathy or arthropathy.
Participants will be blinded to the treatment received. The duration of an individual
participant's participation in this study is 24 weeks. During this time period, patients will
be asked to return to the clinic for in-person follow-up in regular intervals (4 weeks, 12
weeks, and 24 weeks after the injection with either ketorolac or triamcinolone) in order to
assess participants' outcomes. All work related to this project will take place at the Emory
Sports Medicine Complex, Emory Executive Park, Emory Musculoskeletal Institute, the Emory
University Orthopaedic and Spine Hospital, and the Emory Saint Joseph's Hospital. This study
will add to existing knowledge by providing further insight into how wrist arthropathy should
be most optimally conservatively managed.